Apolipoprotein E and Alzheimer's disease: A review of recent studies

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 4, 1997, Pages 675-685

  Higgins, Guy A ^a   Large, Charles H ^a   Rupniak, H Thomas ^a   Barnes, Julie C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Alzheimer's disease; ApoE; cell biology; CNS; cognition; repair; transgenics

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ISOPROTEIN;

ALLELE; ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; BEHAVIOR; CHOLINERGIC SYSTEM; GENOTYPE; HOMOZYGOSITY; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; TRANSGENIC ANIMAL;

ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS E; BRAIN; HUMANS;

ANIMALIA;

EID: 0030933095     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00420-0     Document Type: Article

References (118)

1. Alberts M. J., Graffagnino C., McClenny C., DeLong D., Strittmatter W., Saunders A. M., Roses A. D. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 346:1995;575.
2. Ali S. M., Dunn E., Oostveen J. A., Hall E. D., Carter D. B. Induction of apolipoprotein E mRNA in the hippocampus of the gerbil after transient global ischaemia. Mol. Brain Res. 38:1996;37-44.
3. Arrigada P. V., Growdon J. H., Hedley-Whyte E. T., Hyman B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
4. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrate. Implications for endothelial injury from nitric oxide and superoxide Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
5. Bellosta S., Nathan B. P., Orth M., Dong L.-M., Mahley R. W., Pitas R. E. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270:1995;27063-27071.
6. Benzi G., Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging. 16:1995;661-674.
7. Betard C., Robitaille Y., Gee M., Tiberghien D., Larrivee D., Roy P., Mortimer J. A., Gauvreau D. ApoE allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuro Report. 5:1994;1893-1896.
8. van Bockxmeer F. M. Apolipoprotein E and Alzheimer's. Commentary Nature. 375:1995;28.
9. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
10. Bu G., Maksymovitch E. A., Nerbonne J. M., Schwartz A. L. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J. Biol. Chem. 269:1994;18521-18525.
11. Carter J., Anderton B. The molecular pathology of Alzheimer's disease. Br. J. Hosp. Med. 51:1994;522-528.
12. Chan W., Fornwald J., Brawner M., Wetzler R. Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide A-beta. Biochemistry. 35:1996;7123-7130.
13. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C. Jr., Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Protective effect of apolipoprotein E type 2 allele for late-onset Alzheimer's disease. Nature Genet. 7:1994;180-184.
14. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
15. DeKosky S. T., Scheff S. W. Synapse loss in frontal cortex biopsies in Alzheimer's disease. Correlation with cognitive severity Ann. Neurol. 27:1990;457-464.
16. Diedrich J. F., Minnigan H., Carp R. I., Whitaker J. N., Race R., Frey W. III, Haase A. T. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65:1991;4759-4768.
17. Einstein G., Buranosky R., Crain B. J. Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques. J. Neurosci. 14:1994;5077-5088.
18. Evans K. C., Berger E. P., Cho C. G., Weisgraber K. H., Lansbury P. T. Jr. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation. Implications for the pathogenesis and treatment of Alzheimer's disease Proc. Natl. Acad. Sci. USA. 92:1995;763-767.
19. Gandy S., Stafstrom C., Turner B., Sweeney D., Breslow J., Greengard P., Smith J., Ouimet C. Aged APOE deficient mice. Abnormal learning and glial markers but no obvious neuropathology Soc. Neurosci. Abstr. 21:1995;9.3.
20. Gearing M., Schneider J. A., Robbins R. S., Hollister R. D., Mori H., Games D., Hyman B. T., Mirra S. S. Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 54:1995;833-841.
21. Genis I., Gordon I., Sehayek E., Michaelson D. M. Phosphorylation of tau in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;5-8.
22. Gerlai R. Gene-targetting studies of mammalian behaviour. Is it the mutation or the background genotype? Trends Neurosci. 19:1996;177-186.
23. Goedert M., Sisodia S. S., Price D. L. Neurofibrillary tangles and beta-amyloid deposits in Alzheimer's disease. Curr. Opin. Neurobiol. 1:1991;441-447.
24. Golabek A. A., Soto C., Vogel T., Winiewski T. The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation. J. Biol. Chem. 271:1996;10602-10606.
25. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D. M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
26. Hall E. D., Oostveen J. A., Dunn E., Carter D. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischaemia in gerbils. Exp. Neurol. 135:1995;17-27.
27. Hamos, J. E.; DeGennaro, L. J.; Drachman, D. A.: Synaptic loss in Alzheimer's disease and other dementias. Neurology 39:355-361.
28. Han S.-H., Einstein G., Wiesgraber K. H., Strittmatter W. J., Saunders A. M., Pericak-Vance M., Roses A. D., Schmechel D. E. Apolipoprotein E is localised to the cytoplasm of human cortical neurons. A light and electron microscopic study J. Neuropathol. Exp. Neurol. 53:1994;535-544.
29. Han S.-H., Hullete C., Saunders A. M., Einstein G., Pericak-Vance M., Strittmatter W. J., Roses A. D., Schmechel D. E. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangle in Alzheimer's disease and in age-matched controls. Exp. Neurol. 128:1994;13-26.
30. Harr S. D., Uint L., Hollister R., Hyman B. T., Mendez A. J. Brain expression of apolipoprotein E, J, and A-1 in Alzheimer's disease. J. Neurochem. 66:1996;2429-2435.
31. Haxby J. V., Raffaele K., Gillette J., Schapiro M. B., Rapoport S. I. Individual trajectories of cognitive decline in patients with dementia of the Alzheimer's type. J. Clin. Exp. Neuropsychol. 14:1992;575-592.
32. Hayek T., Oiknine J., Brook J. G., Aviram M. Increased plasma and lipid peroxidation in apoE deficient mice. Biochem. Biophys. Res. Commun. 201:1994;567-574.
33. Higgins G. A., Hardman R., Evans D. J., Fellows L. A., Rupniak H. T. R., Savage T., Hayes B., Barnes J. C. Changes in the expression of hippocampal ApoE, GAP43 and synaptophysin immunoreactivity (IR) following entorhinal cortex lesions in mice. CCNP Meeting:1996;. Toronto;
34. Holtzman D. M., Pitas R. E., Kilbridge J., Nathan B., Mahley R. W., Bu G., Schwartz A. L. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA. 92:1995;9480-9484.
35. Horsburgh K., Nicoll J. A. R. Selective cellular alterations in amyloid precursor protein and apolipoprotein E following transient cerebral ischaemia in the rat. Alzheimer Res. 2:1996;37-42.
36. Houlden H., Crook R., Hardy J., Roques P., Collinge J., Rossor M. Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus. Neurosci. Lett. 174:1994;222-224.
37. Huang D. Y., Weisgraber K. H., Goedert M., Saunders A. M., Roses A. D., Strittmater W. J. ApoE3 binding to tau tandem repeat 1 is abolished by tau serine 262 phosphorylation. Neurosci. Lett. 192:1995;209-212.
38. Huang, D. Y.; Weisgraber, K. H.; Strittmater, W. J.; Matthew, W. D.: Interaction of apolipoprotein E with laminin increases neuronal adhesion and alters neurite morphology. Exp. Neurol.; in press.
39. Hyman B. T., West H. L., Rebeck G. W., Buldyrev S. V., Mantegna R. N., Ukleja M., Havlin S., Stanley H. E. Quantitative analysis of senile plaques in Alzheimer disease. Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome) Proc. Natl. Acad. Sci. 92:1996;3590-3596.
40. Ignatius M. J., Gebicke-Harter P. J., Pate Skene J. H., Schilling J. W., Weisgraber K. H., Mahley R. W., Shooter E. M. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA. 83:1986;1125-1129.
41. Ikeda K., Aizawa T., Haga S., Otsuka N., Mizuguchi M., Namba Y., Machinami R., Kim S. U., Yamamoto T. Very low density lipoprotein receptor and Alzheimer's disease. Roses A. D., Wiesgraber K. H., Christen Y. Apolipoprotein E and Alzheimer's disease. Research & perspectives in Alzheimer's disease. 1996;74-96 Springer, New York.
42. Ishimaru H., Ishikawa K., Ohe Y., Takahashi A., Maruyama Y. Cystatin C and apolipoprotein E immunoreactivities in CA1 neurones in ischaemic gerbil hippocampus. Brain Res. 709:1996;155-162.
43. Jobst K. A., Smith A. D., Szatmari M., Esiri M. M., Jaskowski A., Hindley N., McDonald B., Molyneux A. J. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet. 343:1994;829-830.
44. Kida E., Pluta R., Lossinsky A. S., Golabek A. A., Choi-Miura N.-H., Wisniewski H. M., Mossakowski M. J. Complete cerebral ischaemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the rat. Brain Res. 674:1995;341-346.
45. LaDu M. J., Pederson T. M., Frail D. E., Reardon C. A., Getz G. S., Falduto M. T. Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J. Biol. Chem. 270:1995;9039-9042.
46. Linton M. F., Atkinson J. B., Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267:1995;1034-1037.
47. Mahley R. W. Apolipoprotein E. Cholesterol transport protein with expanding role in cell biology Science. 240:1988;622-630.
48. Mann D. M. A., Pickering-Brown S. M., Siddons M. A., Iwatsubo T., Ihara Y., Asami-Odaka A., Suzuki N. The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype. Neurosci. Lett. 196:1995;105-108.
49. Marder K., Maestre G., Cote L., Mejia H., Alfaro B., Halim A., Tang M., Tycko B., Mayeux R. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology. 44:1994;1330-1331.
50. Martins R. N., Clarnette R., Fisher C., Broe G. A., Brooks W. S., Montgomery P., Gandy S. E. ApoE genotypes in Australia. Roles in early and late onset Alzheimer's disease and Down's syndrome NeuroReport. 6:1995;1513-1516.
51. Masliah E., Fagan A. M., Terry R., Deteresa R., Mallory M., Gage F. H. Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Exp. Neurol. 113:1991;131-142.
52. Masliah E., Mallory M., Alford M., Ge N., Mucke L. Abnormal synaptic regeneration in hAPP695 transgenic and ApoE knockout mice. Iqbal K., Mortimer J. A., Winblad B., Wisniewski H. M. Research advances in Alzheimer's disease and related disorders. 1995;405-414 Wiley and Sons, New York.
53. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., Roses A. D. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136:1995;107-122.
54. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., Terry R. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci. Lett. 174:1994;67-72.
55. Matthews R. T., Beal M. F. Increased 3-nitrotyrosine in brains of ApoE deficient mice. Brain Res. 718:1996;181-184.
56. Matthews D. A., Cotman C., Lynch G. An electron microscope study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. I. Magnitude and time course of degeneration. Brain Res. 115:1976;1-21.
57. Mega M. S., Cummings J. L., Fiorello T., Gornbein J. The spectrum of behavioural changes in Alzheimer's disease. Neurology. 46:1996;130-135.
58. Mercken L., Brion J.-P. Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E. NeuroReport. 6:1995;2381-2384.
59. Mui S., Rebeck G. W., McKenna-Yasek D., Hyman B. T., Brown R. H. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann. Neurol. 38:1995;460-463.
60. Nalbantoglu J., Gilfix B. M., Bertrand P., Robitaille Y., Gauthier S., Rosenblatt D. S., Poirier J. Predictive value of apolipoprotein E genotyping in Alzheimer's disease. Results of an autopsy series and an analysis of several combined studies Ann. Neurol. 36:1994;889-895.
61. Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W., Pitas R. E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264:1994;850-852.
62. Nathan B. P., Chang K.-C., Bellosta S., Brisch E., Ge N., Mahley R. W., Pitas R. E. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerisation. J. Biol. Chem. 270:1995;19791-19799.
63. Newman M. F., Croughwell N. D., Blumenthal J. A., Lowry E., White W. D., Spillane W., Davis R. D., Glower D. D., Smith L. R., Mahanna E. P., Reves J. G. Predictors of cognitive decline after cardiac operation. Ann. Thorac. Surg. 59:1995;1326-1330.
64. Nicoll J. A. R., Roberts G. W., Graham D. I. Apolipoprotein E e4 allele is associated with deposition of amyloid B-protein following head injury. Nature Med. 1:1995;135-137.
65. Ohm T. G., Kirca M., Bohl J., Scharnagl H., Groß W., Marz W. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience. 66:1995;583-587.
66. Ohman T., Dang N., Leboeuf R. C., Furlong C. E., Fukuchi K. Expression of apolipoprotein E inhibits aggregation of the C-terminal fragments of beta-amyloid precursor peptide. Neurosci. Lett. 210:1996;65-68.
67. Palmer A. M., Burns M. A. Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res. 645:1994;338-342.
68. Parasuraman R., Martin A. Cognition in Alzheimer's disease. Disorders of attention and semantic knowledge Curr. Opin. Neurobiol. 4:1994;237-244.
69. Pearlson G. D., Harris G. J., Powers R. E., Barta P. E., Camargo E. E., Chase G. A., Noga J. T., Tune L. E. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch. Gen. Psychiatry. 49:1992;402-408.
70. Piedrahita J. A., Zhang S. H., Hagman J. R., Oliver P. M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targetting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:1992;4471-4475.
71. Plump A. S., Smith J. D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J. G., Rubin E. M., Breslow J. L. Severe hypercholesterolaemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
72. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
73. Poirier J., Baccichet A., Dea D., Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience. 55:1993;81-90.
74. Poirier J., Delisle M.-C., Quirion R., Aubert I., Farlow M., Lahir D., Hui S., Bertrand P., Nalbantoglu J., Gilfix B. M., Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 92:1995;12260-12264.
75. Poirier J., Hess M., May P. C., Finch C. E. Cloning of hippocampal poly(A) RNA sequences that increase after entorhinal cortex lesion in adult rat. Mol. Brain Res. 9:1991;191-195.
76. Poirier J., Hess M., May P. C., Finch C. E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11:1991;97-106.
77. Poirier J., May P. C., Osterburg H. H., Geddes J., Cotman C., Finch C. Selective alterations of mRNA in rat hippocampus after entorhinal cortex lesioning. Proc. Natl. Acad. Sci. USA. 87:1990;303-307.
78. Popko B., Goodrum J. F., Bouldin T. W., Zhang S. H., Maeda N. Nerve regeneration occurs in the absence of apolipoprotein E in mice. J. Neurochem. 60:1993;1155-1158.
79. Rebek G. W., Reiter J. S., Strickland D. K., Hyman B. T. Apolipoprotein E in sporadic Alzheimer's disease. Allelic variation and receptor interactions Neuron. 11:1993;575-580.
80. Reiman E. M., Caselli R. J., Yun L. S., Chen K., Bandy D., Minoshima S., Thibodeau S. N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allelle for apolipoprotein E. N. Engl. J. Med. 334:1996;752-792.
81. Roses A. D. Apolipoprotein E genotyping in differential diagnosis, not prediction, of Alzheimer's disease. Ann. Neurol. 38:1995;6-14.
82. Roses A. D. Apolipoprotein E and Alzheimer's disease. Sci. Am. Sci. Med. 2:1995;16-25.
83. Roses, A. D.: The predictive value of APOE genotyping in the early diagnosis of dementia of the Alzheimer type: Data from three independent series. In: Proceedings of the 5th International Conference on Alzheimer's Disease and Related Disorders. Chichester, UK: John Wiley & Sons; in press.
84. Rossor M. Alzheimer's disease. Br. Med. J. 307:1993;779-782.
85. Samuel W., Terry R., DeTeresa R., Butters N., Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer's dementia. Arch. Neurol. 51:1994;2081-2088.
86. Saunders A. M., Strittmatter W. J., Schmechel D., St. George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gussella J. F., Crapper-McLachlan D., Alberts M. J., Hulette C., Crain B., Goldgaber D., Roses A. D. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
87. Schmechel D. E., Saunders A. M., Strittmatter W. J., Crain B. J., Hulette C. M., Joo S. H., Pericak-Vance M. A., Goldgaber D., Roses A. D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 90:1993;9649-9653.
88. Schmechel D. E., Tiller M. O., Tong P., McSwain M., Han S.-H., Ange R., Burkart D. S., Izard M. K. Pattern of apolipoprotein E immunoreactivity during brain aging. Roses A. D., Weisgraber K. H., Christen Y. Apolipoprotein E and Alzheimer's disease. 1996;29-43 Springer, New York.
89. Schneider J. A., Gearing M., Robbins R. S., de l'Aune W., Mirra S. S. Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann. Neurol. 38:1995;131-135.
90. Scott J. Apolipoprotein E and Alzheimer's disease (commentary). Lancet. 342:1993;696.
91. Seab J. P., Jagust W. J., Wong S. T. S., Roos M. S., Reed B. R., Budinger T. F. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Mag. Res. Med. 8:1988;200-208.
92. Selkoe D. J. Amyloid β protein precursor and the pathogenesis of Alzheimer's disease. Cell. 58:1989;611-612.
93. Siest G., Pillot T., Regis-Bailly A., Leininger-Muller B., Steinmetz J., Galteau M.-M., Visvikas S. Apolipoprotein E. An important gene and protein to follow in laboratory medicine Clin. Chem. 41:1995;1068-1086.
94. Smithies O., Maeda N. Gene targetting approaches to complex genetic diseases. Atherosclerosis and essential hypertension Proc. Natl. Acad. Sci. USA. 92:1995;5266-5272.
95. Snipes G. J., McGuire C. B., Norden J. J., Freeman J. A. Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc. Natl. Acad. Sci. USA. 83:1986;1130-1134.
96. Soininen H. S., Kosunen O., Helisalmi S., Mannermaa A., Paljarvi L., Talasniemi S., Ryynanen M., Riekkinen P. J. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein e4 allele. Neurosci. Lett. 187:1995;79-82.
97. Soininen H. S., Riekkinen P. J. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci. 19:1996;224-228.
98. Sorbi S., Nacmias B., Forleo P., Latorraca S., Gobbini I., Bracco L., Piacentini S., Amaducci L. ApoE allelle frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci. Lett. 177:1994;100-102.
99. Sorbi S., Nacmias B., Piacentini S., Repice A., Latorraca S., Forleo P., Amaducci L. ApoE as a prognostic factor for post-traumatic coma. Nature Med. 1:1995;852.
100. Soto C., Golabek A., Winiewski T., Castano E. M. Alzheimer's beta-amyloid peptide is conformationally modified by apolipoprotein E in vitro. NeuroReport. 7:1996;721-725.
101. Steward O., Cotman C. W., Lynch G. S. Re-establishment of electrophysiologically functional entorhinal cortical input to the dentate gyrus deafferented by ipsilateral entorhinal lesions. Innervation by the contralateral entorhinal cortex Exp. Brain Res. 18:1973;396-414.
102. Steward O., Vinsant S. L. The process of reinnervation in the dentate gyrus of the adult rat. A quantitative electron microscopic analysis of terminal proliferation and reactive synaptogenesis J. Comp. Neurol. 214:1983;370-386.
103. Strittmatter W. J., deSerrano V. In vitro interactions of apolipoprotein E isoforms with tau. Soc. Neurosci. Abstr. 21:1995;400.7.
104. Strittmatter W. J., Roses A. D. Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci. 19:1996;53-77.
105. Strittmatter W. J., Saunders A. M., Schmechel D. E., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E. High avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset Alzheimer's disease Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
106. Strittmatter W. J., Weisgraber K. H., Goedert M., Saunders A. M., Huang D., Corder E. H., Dong L. M., Jakes R., Alberts M. J., Gilbert J. R., Roses A. D. Hypothesis. Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype Exp. Neurol. 125:1994;163-171.
107. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D. E., Saunders A. M., Goldgaber D., Roses A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide. Isoform-specific effects and implications for late-onset Alzheimer's disease Proc. Natl. Acad. Sci. USA. 90:1993;8098-8102.
108. Swanson L. W., Simmons D. M., Hofmann S. L., Goldstein J. L., Brown M. S. Localisation of mRNA for low density lipoprotein receptor and a cholesterol enzyme in rabbit nervous system by in-situ hybridisation. Proc. Natl. Acad. Sci. USA. 85:1988;9821-9825.
109. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease. Synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30:1991;572-580.
110. Tooyama I., Kawamata T., Akiyama H., Kimura H., Moestrup S. K., Glieman J., Matsuo A., McGeer P. L. Subcellular localisation of the low density lipoprotein receptor-related protein (alpha-2 macroglobulin receptor) in human brain. Brain Res. 691:1995;235-238.
111. Troncoso J. C., Kawas C. H., Chang C. K., Folstein M. F., Hedreen J. C. Lack of association of the apoE4 allele with hippocampal sclerosis dementia. Neurosci. Lett. 204:1996;138-140.
112. Uchihara T., Duyckaerts C., He Y., Kobayashi K., Seilhean D., Amouyel P., Hauw J. J. ApoE immunoreactivity and microglial cells in Alzheimer's disease brain. Neurosci. Lett. 195:1995;5-8.
113. van der Vliet A., Eiserich J. P., O'Neill C. A., Halliwell B., Cross C. E. Tyrosine modification by reactive nitrogen species. A closer look Arch. Biochem. Biophys. 319:1995;341-349.
114. Weisgraber K. H. Apolipoprotein E. Structure function relationships Adv. Protein Chem. 45:1994;249-299.
115. Wolf B. B., Lopes M. B. S., VandenBerg S. R., Gonias S. L. Characterisation and immunohistochemical localisation of α2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am. J. Pathol. 141:1992;37-42.
116. Wolfer D. P., Bozicevic-Stagliar M., Lipp H.-P. The role of genetic background in assessing the behaviour of transgenic mice. Soc. Neurosci. Abstr. 21:1995;480.15.
117. Xu P.-T., Schmechel D. E., Rothrock-Christian T., Burkhart D. S., Qui H.-L., Popko B., Sullivan P., Maeda N., Saunders A. M., Roses A. D., Gilbert J. R. Human apolipoprotein E2, E3 and E4 isoform specific transgenic mice. Human-like pattern of neuronal immunoreactivity in the central nervous system not observed in wild type mice Neurobiol. Dis. 3:1996;229-245.
118. Zhang S. H., Reddick R. L., Piedrahita J. A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.